Back

The changing clinical trajectory of patients with valvular infective endocarditis during the SARS COV2 pandemic

12 May 2024 (12:25 - 13:34)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 3 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Roxana-Bianca Piriianu-Masgras

Bucuresti (Romania)

6 More presentations in this session

Presentation thumbnail
In-hospital mortality in infective endocarditis: a score comparison
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Highlighting the importance of risk stratification and management in infective endocarditis
Doctor A. Garcia (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Neurological complications in infective endocarditis: risk factors and outcome.
Doctor J. Mirinha Luz (Almada, PT)
Abstract Slides Video
Presentation thumbnail
The prognostic relevance of neutrophil-to-lymphocyte ratio in infective endocarditis for heart failure patients
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Assessing the impact of evolving infective endocarditis epidemiology on heart failure patients: challenges and implications
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 3

The Event

Event poster

Heart Failure 2024

12 May 2024 12:25 CET
You may be interested in
thumbnail
Congress Presentation
Post-SARS-CoV-2 pandemic changes in the epidemiology and severity of MRSA-related infective endocarditis
thumbnail
Congress Presentation
The effect of COVID-19 pandemic on myocardial infarction care and in-hospital outcome in Kosovo
thumbnail
Congress Presentation
Long-term follow-up after infective endocarditis: comparison of patients who have undergone cardiac surgery versus a conservative therapy with and without an indication for cardiac surgery

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources